Brief: Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results
31/10/2024 11:07
Oct 31 (Reuters) - Madrigal Pharmaceuticals Inc
MDGL.O :
* MADRIGAL PHARMACEUTICALS REPORTS THIRD-QUARTER 2024
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATES
Source text: ID:nGNX2HlpZN
Further company coverage: MDGL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Madrigal Pharmaceuticals
See all newsBrief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule
Madrigal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Madrigal Pharmaceuticals Q2 revenue rises 71% on Rezdiffra demand
U.S. RESEARCH ROUNDUP-Boeing, Coca-Cola, PayPal
Brief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)